,
Greetings from
Freyr Bahrain
With the fastest growing economy and being one of the advanced pharmaceutical and healthcare systems in the region, the Kingdom of Bahrain is a welcoming destination for medicinal products and medical device manufacturers. The National Health Regulatory Authority (NHRA) oversees product / device registrations and respective regulatory procedures. Though the region recognizes certifications from international renowned Regulatory bodies, navigating through demanding obligations might require thorough knowledge on the market.
Freyr, as a proven Regulatory affair consulting partner, assists foreign manufacturers to decode the Regulatory nuances of the Bahrain region and streamlines Regulatory activities for in-time approvals. Freyr’s Regulatory services in Bahrain span across:
- Medical Devices
- Drugs
- Consumer Healthcare Products
Medicinal Products Regulatory Support in Bahrain
The National Health Regulatory Authority (NHRA) in Bahrain is recognized as one of the region’s most efficient and forward‑thinking regulators, making the Kingdom an attractive destination for global pharmaceutical companies. With a clear, supportive Regulatory framework, NHRA oversees product registration, pricing, and compliance to ensure high standards of quality, safety, and efficacy.
Bahrain’s strong Regulatory ecosystem enables faster, smoother, and more predictable market access. The Kingdom further strengthens its appeal through accelerated pathways for products already approved by major reference authorities such as the FDA, EMA, MHRA, and SFDA, positioning Bahrain as a strategic gateway to the GCC pharmaceutical market.
Freyr Solutions supports companies throughout this process with expert gap analysis, eCTD dossier development, submission strategy, and a dedicated NHRA liaison, ensuring a seamless and compliant entry into Bahrain’s thriving pharma landscape.
Freyr Offerings
- Strategic Regulatory Consulting
- Regulatory Affairs & Regulatory intelligence
- Registration pathways and license management services
- New drug application, License renewals
- eCTD submissions
- Preparation of dossiers for the registration of medicines
Freyr Advantages
- Strategic and well-versed local regulatory knowledgebase – NHRA
- Regulatory team with proven global RA expertise
- Proactive and Collaborative approach
- Quick turnarounds and faster time-to-market
- Keeping abreast with region-specific legislation and Regulatory guidelines